Efficacy and safety of bortezomib in patients with renal impairment: Results from the APEX phase 3 study

  1. San-Miguel, J.F.
  2. Richardson, P.G.
  3. Sonneveld, P.
  4. Schuster, M.W.
  5. Irwin, D.
  6. Stadtmauer, E.A.
  7. Facon, T.
  8. Harousseau, J.-L.
  9. Ben-Yehuda, D.
  10. Lonial, S.
  11. Goldschmidt, H.
  12. Reece, D.
  13. Bladé, J.
  14. Boccadoro, M.
  15. Cavenagh, J.D.
  16. Neuwirth, R.
  17. Boral, A.L.
  18. Esseltine, D.-L.
  19. Anderson, K.C.
Revue:
Leukemia

ISSN: 1476-5551,  0887-6924

Année de publication: 2008

Volumen: 22

Número: 4

Pages: 842-849

Type: Article

DOI: 10.1038/SJ.LEU.2405087 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable

La source de données: Scopus